These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19604123)

  • 1. Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area.
    Occleston NL; Fairlamb D; Hutchison J; O'Kane S; Ferguson MW
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1231-9. PubMed ID: 19604123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring.
    Occleston NL; O'Kane S; Laverty HG; Cooper M; Fairlamb D; Mason T; Bush JA; Ferguson MW
    Wound Repair Regen; 2011 Sep; 19 Suppl 1():s38-48. PubMed ID: 21793965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avotermin: a novel antiscarring agent.
    Durani P; Occleston N; O'Kane S; Ferguson MW
    Int J Low Extrem Wounds; 2008 Sep; 7(3):160-8. PubMed ID: 18757391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutics for the prevention and reduction of scarring.
    Occleston NL; O'Kane S; Goldspink N; Ferguson MW
    Drug Discov Today; 2008 Nov; 13(21-22):973-81. PubMed ID: 18824245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.
    Ferguson MW; Duncan J; Bond J; Bush J; Durani P; So K; Taylor L; Chantrey J; Mason T; James G; Laverty H; Occleston NL; Sattar A; Ludlow A; O'Kane S
    Lancet; 2009 Apr; 373(9671):1264-74. PubMed ID: 19362676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase II clinical trial of avotermin versus placebo for scar improvement.
    McCollum PT; Bush JA; James G; Mason T; O'Kane S; McCollum C; Krievins D; Shiralkar S; Ferguson MW
    Br J Surg; 2011 Jul; 98(7):925-34. PubMed ID: 21618480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.
    Occleston NL; Laverty HG; O'Kane S; Ferguson MW
    J Biomater Sci Polym Ed; 2008; 19(8):1047-63. PubMed ID: 18644230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial.
    So K; McGrouther DA; Bush JA; Durani P; Taylor L; Skotny G; Mason T; Metcalfe A; O'Kane S; Ferguson MWJ
    Plast Reconstr Surg; 2011 Jul; 128(1):163-172. PubMed ID: 21701333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trial.
    Bush J; Duncan JAL; Bond JS; Durani P; So K; Mason T; O'Kane S; Ferguson MWJ
    Plast Reconstr Surg; 2010 Nov; 126(5):1604-1615. PubMed ID: 21042116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach for the prophylactic improvement of surgical scarring: avotermin (TGF beta 3).
    Young VL; Bush J; O'Kane S
    Clin Plast Surg; 2009 Apr; 36(2):307-13, viii. PubMed ID: 19309655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations on clinical proof of efficacy for potential scar prevention and reduction therapies.
    Bush JA; McGrouther DA; Young VL; Herndon DN; Longaker MT; Mustoe TA; Ferguson MW
    Wound Repair Regen; 2011 Sep; 19 Suppl 1():s32-7. PubMed ID: 21793964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of avotermin (transforming growth factor β3) in a clinically relevant pig model of long, full-thickness incisional wounds.
    Laverty HG; Occleston NL; Johnson M; Little J; Jones R; Fairlamb D; Ferguson MW; O'Kane S
    J Cutan Med Surg; 2010; 14(5):223-32. PubMed ID: 20868619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beyond TGF-beta: wound healing modulation in filtering glaucoma surgery].
    Meyer-Ter-Vehn T; Klink T; Grehn F; Schlunck G
    Klin Monbl Augenheilkd; 2009 Jan; 226(1):22-6. PubMed ID: 19173159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of buccal mucosa scarring with transforming growth factor β3.
    Ohno S; Hirano S; Kanemaru S; Tateya I; Kitani Y; Kojima T; Nakamura T; Ito J
    Laryngoscope; 2011 Jul; 121(7):1404-9. PubMed ID: 21647892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scar prevention and cosmetically enhanced wound healing using relaxin.
    Stewart DR
    Ann N Y Acad Sci; 2009 Apr; 1160():336-41. PubMed ID: 19416215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation.
    Lu L; Saulis AS; Liu WR; Roy NK; Chao JD; Ledbetter S; Mustoe TA
    J Am Coll Surg; 2005 Sep; 201(3):391-7. PubMed ID: 16125072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical high-molecular-weight hyaluronan and a roofing barrier sheet equally inhibit postlaminectomy fibrosis.
    Akeson WH; Massie JB; Huang B; Giurea A; Sah R; Garfin SR; Kim CW
    Spine J; 2005; 5(2):180-90. PubMed ID: 15749618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wound healing: from embryos to adults and back again.
    Tredget EE; Ding J
    Lancet; 2009 Apr; 373(9671):1226-8. PubMed ID: 19362658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.